Chemical identity
N-Sulfamoylethyl naratriptan pyridinium / 4-[1,5-Bis-(2-Methylsulfamoylethyl)-1H-indol-3-yl]-1-methylpyridinium chloride
CAS 2144776-33-8 · C20H27ClN4O4S2
01Identity
Identifiers and names for this exact compound. Empty fields are left unassigned.
| Lazychem ID | LC-22803 |
|---|---|
| PubChem CID | 71314089 |
| Name | N-Sulfamoylethyl naratriptan pyridinium / 4-[1,5-Bis-(2-Methylsulfamoylethyl)-1H-indol-3-yl]-1-methylpyridinium chloride |
| CAS RN | 2144776-33-8 |
| Molecular formula | C20H27ClN4O4S2 |
| Molecular weight | 487.04 g/mol |
| IUPAC name | 4-[1,5-Bis-(2-Methylsulfamoylethyl)-1H-indol-3-yl]-1-methylpyridinium chloride |
| InChIKey | FSRYNMULJKYDNG-UHFFFAOYSA-M |
02Structure identifiers
![2D structure: N-Sulfamoylethyl naratriptan pyridinium / 4-[1,5-Bis-(2-Methylsulfamoylethyl)-1H-indol-3-yl]-1-methylpyridinium chloride, CAS 2144776-33-8](/structures/pubchem/71314089/2144776-33-8-n-sulfamoylethyl-naratriptan-pyridinium-4-1-5-bis-2-methylsulfamoylethyl-1h-indol-3-yl-1-m-2d-structure-900.png)
Structure facts for this exact identity.
| Molecular formula | C20H27ClN4O4S2 |
|---|---|
| InChIKey | FSRYNMULJKYDNG-UHFFFAOYSA-M |
| Ring count | 3 |
| Defined stereocentres | 0 |
| Unassigned stereocentres | 0 |
| SMILES | CNS(=O)(=O)CCC1=CC2=C(C=C1)N(C=C2C3=CC=[N+](C=C3)C)CCS(=O)(=O)NC.[Cl-] |
|---|---|
| InChI | InChI=1S/C20H27N4O4S2.ClH/c1-21-29(25,26)12-8-16-4-5-20-18(14-16)19(17-6-9-23(3)10-7-17)15-24(20)11-13-30(27,28)22-2;/h4-7,9-10,14-15,21-22H,8,11-13H2,1-3H3;1H/q+1;/p-1 |
03India status for this compound
These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.
| NDPS / RCS | NOT FOUND IN REVIEWED ENTRIES | CAS 2144776-33-8 was not found in the reviewed exact-identity entries. Generic, class, analogue, salt and isomer provisions were not evaluated. |
|---|---|---|
| SCOMET | NOT FOUND IN REVIEWED CAS ENTRIES | CAS 2144776-33-8 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated. |
- Narcotic Drugs and Psychotropic Substances Act, 1985, ScheduleDepartment of Revenue, Government of India · source version 1985-09-16
- Controlled-substances notifications and amendmentsDepartment of Revenue, Government of India · source version 2026-03-11
- Appendix 3, SCOMET ListDirectorate General of Foreign Trade, Government of India · source version 2024-09-02
04Names and relationships
Associated parent compound
Naratriptan
View API and impurity familyOther names
- N-Sulfamoylethyl Naratriptan Pyridinium
- 4-[1, 5-Bis-(2-Methylsulfamoylethyl)-1H-indol-3-yl]-1-methylpyridinium chloride
- 4-(1,5-bis(2-(N-methylsulfamoyl)ethyl)-1H-indol-3-yl)-1-methylpyridin-1-ium chloride
- Naratriptan Impurity F
- Naratriptan Impurity 4
- N-Sulfamoylethyl Naratriptan Pyridinium Chloride
- NARATRIPTAN HYDROCHLORIDE IMPURITY, 4-(1,5-BIS-(2-METHYLSULFAMOYL-ETHYL)-1H-INDOL-3-YL)-1-METHYLPYRIDINIUM CHLORIDE- [USP IMPURITY]
05Documented history
Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.
No verified discovery, first report, occurrence, use or issue event is currently available for this identity.
06Sources
- S01PubChem compound record, CID 71314089
Names and machine-readable chemical identity properties.
- S02NCBI website and molecular data policies
Reuse policy for NCBI molecular data. This page does not reproduce vendor descriptions or contributed narrative text.
- S03Narcotic Drugs and Psychotropic Substances Act, 1985, Schedule
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S04Controlled-substances notifications and amendments
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S05Appendix 3, SCOMET List
Directorate General of Foreign Trade, Government of India. Used for the exact-compound India status shown on this page.
